RecruitingPhase 3NCT06742190
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
Studying Multifocal motor neuropathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- argenx
- Intervention
- Empasiprubart(biological)
- Enrollment
- 115 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2029
Study locations (30)
- HonorHealth Neurology - Bob Bove Neuroscience Institute - Neurology, Scottsdale, Arizona, United States
- The Neurology Group, Pomona, California, United States
- Samir Macwan, M.D., Inc., Rancho Mirage, California, United States
- University of California San Francisco, San Francisco, California, United States
- University of Colorado - Anschutz Cancer Pavilion (Neuro Onc Clinic), Aurora, Colorado, United States
- Yale University School of Medicine, New Haven, Connecticut, United States
- Medstar Health Research Institute, Washington D.C., District of Columbia, United States
- EZR Research LLC, Boca Raton, Florida, United States
- Healthcare Innovations Institute, LLC, Coral Springs, Florida, United States
- University of Miami Miller School of Medicine, Miami, Florida, United States
- University of South Florida, Tampa, Florida, United States
- Northwestern University, Chicago, Illinois, United States
- Indiana University Health Neuroscience Center, Indianapolis, Indiana, United States
- University of Kansas Medical Center, Fairway, Kansas, United States
- Perelman Center for Advanced Medicine, Columbia, Maryland, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06742190 on ClinicalTrials.govOther trials for Multifocal motor neuropathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06537999A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor NeuropathyDianthus Therapeutics
- ACTIVE NOT RECRUITINGNCT05988073A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathyargenx
- ACTIVE NOT RECRUITINGPHASE2NCT05405361A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathyargenx